​

Twist Bioscience Ownership | Who Owns Twist Bioscience?

OverviewForecastRevenueFinancialsChartTranscripts

Twist Bioscience Ownership Summary

Twist Bioscience is owned by 116.41% institutional investors, 1.88% insiders. Ark investment management is the largest institutional shareholder, holding 10.67% of TWST shares. ARK Innovation ETF is the top mutual fund, with 6.24% of its assets in Twist Bioscience shares.

TWST Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTwist Bioscience116.41%1.88%-18.29%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryDiagnostics & Research Stocks57.29%10.84%31.88%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ark investment management6.40M10.67%$235.47M
Blackrock funding, inc. /de6.28M10.46%$230.91M
Vanguard group5.81M9.92%$269.86M
Blackrock5.42M9.33%$267.28M
Artisan partners limited partnership5.06M8.44%$186.20M
William blair investment management3.91M6.51%$143.72M
Invesco3.58M6.12%$166.57M
State street2.64M4.54%$130.16M
Edgepoint investment group2.39M3.98%$87.78M
Nikko asset management americas2.30M3.83%$84.50M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tao capital management lp828.82K22.36%$30.49M
First light asset management945.03K4.51%$34.77M
Seaport global advisors15.95K2.81%$785.97K
Iron triangle partners lp526.46K2.64%$25.94M
Ark investment management6.40M1.73%$235.47M
Soleus capital management354.40K0.86%$13.04M
Nikko asset management americas2.30M0.84%$84.50M
Brandywine managers20.97K0.77%$771.49K
Edgepoint investment group2.39M0.66%$87.78M
Highmark wealth management39.46K0.49%$1.11M

Top Buyers

HolderShares% AssetsChange
Edgepoint investment group2.39M0.66%1.27M
Point72 asset management2.16M0.16%725.54K
Blackrock funding, inc. /de6.28M0.00%643.58K
Balyasny asset management628.24K0.03%567.48K
Thrivent financial for lutherans1.51M0.14%532.04K

Top Sellers

HolderShares% AssetsChange
State street2.64M0.01%-798.01K
Artisan partners limited partnership5.06M0.27%-790.34K
Jpmorgan chase1.80M0.01%-676.06K
Driehaus capital management---388.64K
Blackrock5.42M0.01%-351.15K

New Positions

HolderShares% AssetsChangeValue
Iron triangle partners lp526.46K2.64%526.46K$25.94M
Soleus capital management354.40K0.86%354.40K$13.04M
Norges bank163.21K0.00%163.21K$7.58M
Abrdn161.40K0.01%161.40K$5.94M
Jupiter asset management53.03K0.02%53.03K$1.95M

Sold Out

HolderChange
Tfc financial management-1.00
Jfs wealth advisors-1.00
Financial gravity asset management-2.00
Corecap advisors-7.00
Td capital management-8.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025242-8.33%69,840,7412.16%1160.89%112-17.65%867.50%
Mar 31, 20252643.53%69,120,8934.14%1150.92%1368.80%81-1.22%
Dec 31, 2024163-34.01%51,992,058-21.11%880.69%86-30.08%41-46.75%
Sep 30, 2024243-9.67%65,818,343-0.32%1130.88%120-23.57%774.05%
Jun 30, 202426910.25%66,027,981-1.45%1130.84%15733.05%74-3.90%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Innovation ETF3.77M6.24%-57.75K
ARK Disruptive Innovation Full Composite3.72M6.16%183.13K
ARK Genomic Revolution ETF2.16M3.58%-7.70K
ARK Genomic Revolution2.09M3.46%-167.44K
Vanguard Total Stock Mkt Idx Inv1.79M2.97%-37.91K
Vanguard US Total Market Shares ETF1.74M2.92%1.75K
iShares Russell 2000 ETF1.43M2.36%-
Vanguard Small Cap Index1.38M2.29%-9.23K
Nikko AM ARK Disruptive Innovation A USD1.07M1.78%-9.40K
Nikko AM ARK Pstv Chg Innovt P JPY Acc1.04M1.74%-50.08K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 23, 2025Finn Patrick John President and COOSell$69.16K
Oct 08, 2025Laponis Adam Chief Financial OfficerSell$93.45K
Oct 09, 2025Laponis Adam Chief Financial OfficerSell$82.86K
Oct 06, 2025Laponis Adam Chief Financial OfficerSell$189.10K
Oct 06, 2025Leproust Emily M. Chief Executive OfficerSell$1.01M

Insider Transactions Trends

DateBuySell
2025 Q4-12
2025 Q3-26
2025 Q2-27
2025 Q1-28
2024 Q4-34

TWST Ownership FAQ

Who Owns Twist Bioscience?

Twist Bioscience shareholders are primarily institutional investors at 116.41%, followed by 1.88% insiders and -18.29% retail investors. The average institutional ownership in Twist Bioscience's industry, Diagnostics & Research Stocks, is 57.29%, which Twist Bioscience exceeds.

Who owns the most shares of Twist Bioscience?

Twist Bioscience’s largest shareholders are Ark investment management (6.4M shares, 10.67%), Blackrock funding, inc. /de (6.28M shares, 10.46%), and Vanguard group (5.81M shares, 9.92%). Together, they hold 31.05% of Twist Bioscience’s total shares outstanding.

Does Blackrock own Twist Bioscience?

Yes, BlackRock owns 9.33% of Twist Bioscience, totaling 5.42M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 267.28M$. In the last quarter, BlackRock decreased its holdings by -351K shares, a -6.08% change.

Who is Twist Bioscience’s biggest shareholder by percentage of total assets invested?

Tao capital management lp is Twist Bioscience’s biggest shareholder by percentage of total assets invested, with 22.36% of its assets in 828.82K Twist Bioscience shares, valued at 30.49M$.

Who is the top mutual fund holder of Twist Bioscience shares?

ARK Innovation ETF is the top mutual fund holder of Twist Bioscience shares, with 6.24% of its total shares outstanding invested in 3.77M Twist Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools